What does CUSIP 71426VAK4 represent in this 13F holders report?

CUSIP 71426VAK4 is the security identifier for 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 used to aggregate holder disclosures.

How many institutions held 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 in Q2 2016?

15 institutional investors reported 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 for Q2 2016. Use the holders table for investor-level position and value details.

PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0

CUSIP: 71426VAK4

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Debt / DBCV 4.250% 4/0
Market price (% of par): 23.0%
Total 13F principal: $128,000,000
Principal change: +$128,000,000
Total reported market value: $29,010,000
Number of holders: 15
Value change: +$29,010,000
Number of buys: 15

Quarterly Holders Quick Answers

What is CUSIP 71426VAK4?
CUSIP 71426VAK4 identifies 71426VAK4 - PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016

Recent filing periods for CUSIP 71426VAK4:

Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 as of Q2 2016

As of 30 Jun 2016, PERNIX THERAPEUTICS HLDGS IN - DBCV 4.250% 4/0 was held by 15 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $128,000,000 in principal (par value) of the bond. The largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, Telemetry Investments, L.L.C., BABSON CAPITAL MANAGEMENT LLC, venBio Select Advisor LLC, Stonepine Capital Management, LLC, Jefferies Group LLC, and Aisling Capital LLC. This page lists 15 institutional bondholders reporting positions for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.